How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,710 results for

Thromboembolic Disease in Pregnancy

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. (PubMed)

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Venous thromboembolism (VTE), although rare, is a major cause of maternal mortality and morbidity, and methods of prophylaxis are therefore often used for women considered to be at risk. This may include women who have given birth by caesarean section, those with a personal or family history of VTE and women with inherited or acquired thrombophilias (conditions that predispose people to thrombosis). Many (...) the Cochrane Pregnancy and Childbirth Group's Trials Register (27 November 2013). Randomised trials comparing one method of thromboprophylaxis with placebo or no treatment, and randomised trials comparing two (or more) methods of thromboprophylaxis.At least two review authors assessed trial eligibility and quality and extracted the data.Nineteen trials, at an overall moderate risk of bias, met the inclusion criteria for the review. Only 16 trials, involving 2592 women, assessing a range of methods

Full Text available with Trip Pro

2014 Cochrane

2. Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease

Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease ACEP // Acute Venous Thromboembolic Disease Popular Recommendations PEER ultrasound LLSA sepsis Log In Log In Topics Practice Education Advocacy About ACEP Topics TOPICS Quick Access Current News Practice Administration Life as a Physician Patient Care By Medical Focus Education In Education Bedside Tools Upcoming Conferences Earn CME Now (...) SERVE WHAT WE BELIEVE / / Acute Venous Thromboembolic Disease Acute Venous Thromboembolic Disease Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease Scope of Application. This guideline is intended for physicians working in emergency departments (EDs). Inclusion Criteria. This guideline is intended for adult patients presenting to the ED with suspected or known acute venous thromboembolism (ie

2018 American College of Emergency Physicians

3. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period. (PubMed)

Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period. Essentials Risk of pregnancy-related venous thromboembolism may be increased in inflammatory bowel disease. We performed a study on inflammatory bowel disease and pregnancy-related venous thromboembolism. Inflammatory bowel disease is a risk factor for pregnancy-related venous thromboembolism. Proper disease control before conception is pivotal to avoid venous thromboembolism.Background (...) The incidence of inflammatory bowel disease (IBD) increases, and thus is more common, in pregnant women. IBD is a risk factor for venous thromboembolism (VTE) but it is not clear whether IBD predisposes women to an excess risk of VTE during pregnancy and the postpartum period. Methods This was a nationwide population-based cohort study of all deliveries during 1980-2013 in Denmark, using data from two nationwide health registries: the Danish National Patient Registry and the Medical Birth Registry. We

Full Text available with Trip Pro

2017 Journal of Thrombosis and Haemostasis

4. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group

Clinical Care Pathway. LARC, long-acting, reversible contraception. Figure 2 Pregnancy planning and conception. ACOG, American College of Obstetricians and Gynecologists; LARC, long-acting, reversible contraception. Figure 3 Nine-month plan. Figure 4 Decision algorithm for mode of delivery. GBS, group B streptococcus; VTE, venous thromboembolism. Figure 5 Post-delivery care for mother and baby. AAP, American Academy of Pediatrics; ASQ, Ages and Stages Questionnaire; CDC, Centers for Disease Control (...) Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group - Gastroenterology Email/Username: Password: Remember me Search AGA Journals Search Terms Search within Search To read this article in full, please review your options for gaining

2019 American Gastroenterological Association Institute

5. Management of Cardiovascular Diseases during Pregnancy

Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article navigation 07 September 2018 Article Contents Article Navigation 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Vera Regitz-Zagrosek Chairperson Corresponding authors. Vera Regitz-Zagrosek, Charité Universitaetsmedizin Berlin, Institute for Gender in Medicine, CCR, DZHK, partner site Berlin, Hessische Str 3-4, 10115 Berlin, Germany, Tel: +49 30 450 525 288, Fax: +49 30 450 7 525 288, E-mail: . Search for other works by this author

Full Text available with Trip Pro

2018 European Society of Cardiology

6. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

the risk of venous thromboembolism (VTE) and bleeding (see recommendation 1.1.2 for all medical patients, 1.1.5 for all surgical patients, 1.1.9 for all pregnant women and all women who gave birth or had a miscarriage or termination of pregnancy in the past 6 weeks, 1.8.1 for all people admitted to the critical care unit and 1.9.1 for all acute psychiatric patients). [2018] [2018] P People admitted to hospital eople admitted to hospital Medical patients Medical patients 1.1.2 Assess all medical (...) a miscarriage or having a termination of Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 7 of 41pregnancy or or if their clinical condition changes and and they: are pregnant or or gave birth, had a miscarriage or had a termination of pregnancy within the past 6 weeks. [2018] [2018] 1.2 Giving

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

7. Thromboembolic Disease in Pregnancy

Thromboembolic Disease in Pregnancy Thromboembolic Disease in Pregnancy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Thromboembolic (...) Disease in Pregnancy Thromboembolic Disease in Pregnancy Aka: Thromboembolic Disease in Pregnancy , Deep Vein Thrombosis in Pregnancy , Deep Venous Thrombosis During Pregnancy , DVT in Pregnancy , DVT Prophylaxis in Pregnancy II. Epidemiology Venous Thrombosis risk: 0.5 to 3 per 1000 pregnancies risk is increased 5 fold in pregnancy DVT occurs equally in all trimesters (but increases with each trimester and especially postpartum) III. Pathophysiology Hypercoagulation in pregnancy Procoagulants

2018 FP Notebook

8. Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Antenatal assessment and management

Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Antenatal assessment and management Great state. Great opportunity. Department of Health State of Queensland (Queensland Health) 2014 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Antenatal assessment and management of VTE prophylaxis High Risk Factors • Single prior unprovoked VTE • Single prior VTE pregnancy or COCP related • Single (...) • Assess the risks associated with VTE prophylaxis (guideline section 1.4) • Discuss options for VTE prophylaxis with the woman • Document a plan of care • Liaise with a team experienced in prophylactic assessment/management as required • Refer to the full text of the guideline for detailed prophylaxis assessment and management High Risk • Discuss GCS • # LMWH prophylaxis • Consider IPC if hospitalised Lower Risk Queensland Clinical Guideline: Venous thromboembolism (VTE) prophylaxis in pregnancy

2014 Queensland Health

9. Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Postnatal assessment and management

Flowchart: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium, Postnatal assessment and management Great state. Great opportunity. Department of Health State of Queensland (Queensland Health) 2014 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Postnatal assessment and management of VTE prophylaxis High Risk Factors • Antenatal LMWH prophylaxis (refer to antenatal VTE prophylaxis flow chart) • Any (...) with a team experienced in prophylactic assessment/management as required • Refer to the full text of the guideline for detailed prophylaxis assessment and management High Risk • GCS • # LMWH prophylaxis for 6 weeks • Consider IPC if hospitalised Lower Risk • Discuss GCS • Consider # LMWH prophylaxis until discharge or fully mobile Queensland Clinical Guideline: Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium. Guideline No: MN14.9-V5-R19 Moderate Risk • Discuss GCS • # LMWH

2014 Queensland Health

10. Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium

: a practical guide. Sydney: Elsevier; 2008. 6. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. New England Journal of Medicine. 2008; 359(19):2025-33. 7. The American College of Obstetricians and Gynecologists. Practice Bulletin Number 123. Thromboembolism in pregnancy. Obsetrics and Gynecology. 2011; 118(3):718-29. 8. Centre for Maternal and Child Enquiries (CMACE). Saving mothers' lives: reviewing maternal deaths to make motherhood safer. 2006-2008. The eighth report on confidential (...) enquiries into maternal deaths in the United Kingdom. BJOG. 2011; 118 (Suppl. 1):1-203. 9. Tooher R, Gates S, Dowswell T, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2010; (5):CD001689. 10. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No.37a. 2009. 11. Scottish Intercollegiate Guidelines Network (SIGN). Prevention

2014 Queensland Health

11. Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium

: a practical guide. Sydney: Elsevier; 2008. 6. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. New England Journal of Medicine. 2008; 359(19):2025-33. 7. The American College of Obstetricians and Gynecologists. Practice Bulletin Number 123. Thromboembolism in pregnancy. Obsetrics and Gynecology. 2011; 118(3):718-29. 8. Centre for Maternal and Child Enquiries (CMACE). Saving mothers' lives: reviewing maternal deaths to make motherhood safer. 2006-2008. The eighth report on confidential (...) enquiries into maternal deaths in the United Kingdom. BJOG. 2011; 118 (Suppl. 1):1-203. 9. Tooher R, Gates S, Dowswell T, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2010; (5):CD001689. 10. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No.37a. 2009. 11. Scottish Intercollegiate Guidelines Network (SIGN). Prevention

2014 Clinical Practice Guidelines Portal

12. Venous thromboembolism (VTE) prophylaxis in pregnancy and the puerperium

: a practical guide. Sydney: Elsevier; 2008. 6. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. New England Journal of Medicine. 2008; 359(19):2025-33. 7. The American College of Obstetricians and Gynecologists. Practice Bulletin Number 123. Thromboembolism in pregnancy. Obsetrics and Gynecology. 2011; 118(3):718-29. 8. Centre for Maternal and Child Enquiries (CMACE). Saving mothers' lives: reviewing maternal deaths to make motherhood safer. 2006-2008. The eighth report on confidential (...) enquiries into maternal deaths in the United Kingdom. BJOG. 2011; 118 (Suppl. 1):1-203. 9. Tooher R, Gates S, Dowswell T, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2010; (5):CD001689. 10. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No.37a. 2009. 11. Scottish Intercollegiate Guidelines Network (SIGN). Prevention

2014 Clinical Practice Guidelines Portal

13. Pregnancy and Risk of Venous Thromboembolism

Device Product: No Keywords provided by Hospices Civils de Lyon: low molecular weight heparin (LMWH) Lyon VTE-score pregnancy thromboprophylaxis venous thromboembolism quality of life cost utility Additional relevant MeSH terms: Layout table for MeSH terms Thromboembolism Venous Thromboembolism Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases (...) Pregnancy and Risk of Venous Thromboembolism Pregnancy and Risk of Venous Thromboembolism - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pregnancy and Risk of Venous Thromboembolism (PRESCOT) The safety

2018 Clinical Trials

14. Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer

whether the risk of pulmonary embolism and venous thromboembolism during the first trimester of IVF pregnancies is associated with both fresh and frozen embryo transfer. A population-based cohort study with linked data from nationwide registries on women in Sweden giving birth to their first child 1992-2012 Condition or disease Intervention/treatment Assisted Reproductive Techniques Pregnancy Pulmonary Embolism Venous Thromboembolism Fresh Embryo Transfer Frozen Embryo Transfer Procedure: Fresh (...) -regulated Device Product: No Keywords provided by Peter Henriksson, Karolinska Institutet: In vitro fertilization Assisted Reproductive Techniques Pulmonary embolism Venous Thromboembolism Pregnancy Additional relevant MeSH terms: Layout table for MeSH terms Thromboembolism Embolism Venous Thromboembolism Pulmonary Embolism Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases

2018 Clinical Trials

15. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

or likely to spend a substantial proportion of the day in bed or in a chair), pregnancy or puerperium – or in a patient who is having hormonal therapy (oral contraceptive or hormone replacement therapy). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 17 of 26Pro Proximal D ximal DVT VT DVT in the popliteal vein or above. Proximal (...) Venous thromboembolic diseases: diagnosis, management and thrombophilia testing V Venous thromboembolic diseases: enous thromboembolic diseases: diagnosis, management and diagnosis, management and thrombophilia testing thrombophilia testing Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg144 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

16. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association

Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February (...) 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 Free Access article Share on Jump to Free Access article Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association , RN, MN, FAHA, Chair , MD, FRCP, Co-Chair , MD , MD , MD , MD, DPhil , MD, FAHA, FRCPC , MD , and MD, FRCPC MD, FAHAOn behalf of the American Heart Association Council

Full Text available with Trip Pro

2017 American Heart Association

17. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease. (PubMed)

Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease. Cardiac disease is 1 of the major causes of maternal mortality. We studied pregnancy outcomes in women with rheumatic mitral valve disease.The Registry of Pregnancy and Cardiac Disease is an international prospective registry, and consecutive pregnant women with cardiac disease were included. Pregnancy outcomes in all women with rheumatic mitral valve disease (...) and no prepregnancy valve replacement is described in the present study (n=390). A maternal cardiac event was defined as cardiac death, arrhythmia requiring treatment, heart failure, thromboembolic event, aortic dissection, endocarditis, acute coronary syndrome, and hospitalization for other cardiac reasons or cardiac intervention. Associations between patient characteristics and cardiac outcomes were checked in a 3-level model (patient-center-country).Most patients came from emerging countries (75%). Mitral

2018 Circulation

18. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. (PubMed)

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial or venous thrombosis (or both) and/or pregnancy morbidity in association with the presence of antiphospholipid antibodies. The prevalence is estimated at 40 to 50 cases per 100,000 people. The most common sites of thrombosis are cerebral arteries and deep veins

Full Text available with Trip Pro

2017 Cochrane

19. Recommendations for the prevention of pregnancy-associated venous thromboembolism

impact of maternal obesity on obstetric practice , Australian and New Zealand Journal of Obstetrics and Gynaecology , 52 , 5 , (409-411) , (2012) . Emily Bain, Agnes Wilson, Rebecca Tooher, Simon Gates, Lucy-Jane Davis and Philippa Middleton , Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period , Cochrane Database of Systematic Reviews , 10.1002/14651858.CD001689.pub3 , (2014) . Ida Martinelli, Valerio De Stefano and Pier M. Mannucci , Inherited risk factors (...) Recommendations for the prevention of pregnancy-associated venous thromboembolism Recommendations for the prevention of pregnancy‐associated venous thromboembolism - McLINTOCK - 2012 - Australian and New Zealand Journal of Obstetrics and Gynaecology - Wiley Online Library Search within Search term Search term Opinion Recommendations for the prevention of pregnancy‐associated venous thromboembolism National Women’s Health, Auckland City Hospital, Grafton, Auckland, New Zealand Department

2012 Clinical Practice Guidelines Portal

20. An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03644992 Recruitment

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>